RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells
RNA-seq (gene expression) · human · 28 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 28 samples: 7 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumorsScience advances · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE254547_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1071010 and SRA study SRP486729. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 28 samples.
How we read this: 7 replicated groups read from 28 sample titles; they account for 28 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8045720 TMIGD2, invitro, Donor 2 TMIGD2, invitro, Dono
- GSM8045721 TMIGD2, invitro, Donor 3 TMIGD2, invitro, Dono
- GSM8045722 TMIGD2, invitro, Donor 4 TMIGD2, invitro, Dono
- GSM8045723 TMIGD2, invitro, Donor 5 TMIGD2, invitro, Dono
- GSM8045724 CD28_41BB, invitro, Donor 2 CD28_41BB, invitro, Dono
- GSM8045725 CD28_41BB, invitro, Donor 3 CD28_41BB, invitro, Dono
- GSM8045726 CD28_41BB, invitro, Donor 4 CD28_41BB, invitro, Dono
- GSM8045727 CD28_41BB, invitro, Donor 5 CD28_41BB, invitro, Dono
- GSM8045728 TMIGD2, invivo, Donor 2 TMIGD2, invivo, Dono
- GSM8045729 TMIGD2, invivo, Donor 3 TMIGD2, invivo, Dono
- GSM8045730 TMIGD2, invivo, Donor 4 TMIGD2, invivo, Dono
- GSM8045731 TMIGD2, invivo, Donor 5 TMIGD2, invivo, Dono
- GSM8045732 CD28_41BB, invivo, Donor 2 CD28_41BB, invivo, Dono
- GSM8045733 CD28_41BB, invivo, Donor 3 CD28_41BB, invivo, Dono
- GSM8045734 CD28_41BB, invivo, Donor 4 CD28_41BB, invivo, Dono
- GSM8045735 CD28_41BB, invivo, Donor 5 CD28_41BB, invivo, Dono
- GSM8045736 B7H3_TMIGD2, invitro, Donor 1 B7H3_TMIGD2, invitro, D…
- GSM8045737 B7H3_TMIGD2, invitro, Donor 2 B7H3_TMIGD2, invitro, D…
- GSM8045738 B7H3_TMIGD2, invitro, Donor 3 B7H3_TMIGD2, invitro, D…
- GSM8045739 B7H3_TMIGD2, invitro, Donor 4 B7H3_TMIGD2, invitro, D…
- GSM8045740 B7H3_CD28_41BB, invitro, Donor 1 B7H3_CD28_41BB, invitro…
- GSM8045741 B7H3_CD28_41BB, invitro, Donor 2 B7H3_CD28_41BB, invitro…
- GSM8045742 B7H3_CD28_41BB, invitro, Donor 3 B7H3_CD28_41BB, invitro…
- GSM8045743 B7H3_CD28_41BB, invitro, Donor 4 B7H3_CD28_41BB, invitro…
- GSM8045744 CD19, invitro, Donor 1 CD19, invitro, Dono
- GSM8045745 CD19, invitro, Donor 2 CD19, invitro, Dono
- GSM8045746 CD19, invitro, Donor 3 CD19, invitro, Dono
- GSM8045747 CD19, invitro, Donor 4 CD19, invitro, Dono
- GSE254546 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells to CD19.CD28.4-1BB CAR-T cells in vitro 12 samples shares tmigd2, b7-h3, 4-1bb, car-t, cd28, comparison
- GSE254544 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells in vitro 8 samples shares tmigd2, b7-h3, 4-1bb, car-t, cd28, comparison
- GSE254545 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells in vivo. 8 samples shares tmigd2, b7-h3, 4-1bb, car-t, cd28, comparison
- GSE276932 Gene expression in self-activating CAR-T cells with CD28 or 4-1BB costimulatory domain and G4S or Whilow218 linker. 15 samples shares 4-1bb, car-t, cd28
- GSE289423 Enhanced Antitumoral Activity of the Academic CAR-T ARI0002h Against Normal and Low BCMA Expressing Myeloma Cells After Incorporating a Transmembrane CD28 Domain 8 samples shares car-t, cd28
- GSE267821 4-1BB causes CAR-T cell death via sequestration of the ubiquitin-modifying enzyme A20 22 samples shares 4-1bb, car-t
- GSE297676 Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single cell RNA sequencing 57 samples shares car-t, comparison
- GSE286827 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy 87 samples shares 4-1bb
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.